(19)
(11) EP 2 220 065 A2

(12)

(88) Date of publication A3:
23.04.2009

(43) Date of publication:
25.08.2010 Bulletin 2010/34

(21) Application number: 08794832.9

(22) Date of filing: 28.07.2008
(51) International Patent Classification (IPC): 
C07D 333/40(2006.01)
C07D 409/12(2006.01)
A61K 31/381(2006.01)
C07D 333/70(2006.01)
C07D 495/04(2006.01)
(86) International application number:
PCT/US2008/009142
(87) International publication number:
WO 2009/017719 (05.02.2009 Gazette 2009/06)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

(30) Priority: 30.07.2007 US 962640 P

(71) Applicant: ENCYSIVE PHARMACEUTICALS, INC.
New York, NY 10017-5755 (US)

(72) Inventors:
  • ANDERSON, Eric, C.
    Houston, TX 77005 (US)
  • BIEDIGER, Ronald, J.
    Houston, TX 77042 (US)
  • CHEN, Jie
    Houston, TX 77036 (US)
  • DUPRE, Brian
    Houston, TX 77042 (US)
  • LORY, Pedro
    2018 Antwerp (BE)
  • MARKET, Robert, V.
    Pearland, TX 77584 (US)
  • MONK, Keith, A.
    League City, TX 77573 (US)
  • SAVAGE, Michael, M.
    Pearland, TX 77581 (US)
  • TENNYSON, Reginald
    Missouri City, TX 77459 (US)
  • YOUNG, Brandon, M.
    Germantown, TN 38138 (US)

(74) Representative: Laurent, Claire et al
Pfizer Limited European Patent Department Ramsgate Road
Sandwich, Kent CT13 9NJ
Sandwich, Kent CT13 9NJ (GB)

   


(54) MODULATORS OF CCR9 RECEPTOR AND METHODS OF USE THEREOF